Refining PCI plannings and decision-making with novel technologies

Session comprising selected EuroPCR 2026 abstract submissions

Summary

This session highlights cutting-edge technologies that enhance PCI planning and decision-making. It covers the clinical populations benefiting from QFR-guided revascularisation, prognostic insights from radial wall strain in DCB-treated vessels, and advances in artificial intelligence and machine learning to assess ischemia and predict PCI outcomes, especially in complex calcified lesions.

Presentations available when logged in:

  • Who benefits from QFR-guided revascularisation? Defining beneficial population and its key feature
  • Prognostic value of RWS-derived plaque vulnerability in DCB-treated de novo large coronary vessels
  • Artificial intelligence improves vessel level ischaemia assessment in calcified coronary lesions
  • Utility of FFR-CT in guiding clinical decision-making in patients with calcified coronary stenosis
  • Predicting functional results of PCI using machine learning
  • Angiography-derived radial wall strain improves prediction of vessel events post-PCI in ACS patients